The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19

INTERVENTION: Intervention 1: "Intervention group:" This group consumes the Trachyspermum copticum syrup. The Trachyspermum copticum plant is a member of the Umbrella family. The total extract of this plant is used.The concentration of this syrup is 10% of the aqueous extract of Trachyspermum copticum. This syrup is administered three times daily for two weeks, 5 ml each time, a total of 15 ml daily. The syrup is made by Shahid Beheshti School of Pharmacy. Intervention 2: "Control group:" This group is taking placebo. Placebo syrup have the same size and shape as the drug.The placebo syrup contains all the basic ingredients of a syrup without the addition of herbal medicine. The placebo syrup is made by Shahid Beheshti School of Pharmacy. CONDITION: Patients with Corona Virus. ; Coronavirus infection, unspecified U07.1 PRIMARY OUTCOME: Level of CRP in serum. Timepoint: One day before the intervention and one day after the intervention is measured. Method of measurement: Using the ELISA technique. The rate of lung inflammation. Timepoint: One day before the intervention and one day after the intervention is measured. Method of measurement: CT SCAN. INCLUSION CRITERIA: Having informed consent to participate in the study The definitive diagnosis of COVID‐19 Failure to attend another clinical trial simultaneously